You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Medical Care

Latent Tuberculosis Infection (LTBI) Testing Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

Summary

Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.

The global Latent Tuberculosis Infection (LTBI) Testing market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.

Based on the type of product, the global Latent Tuberculosis Infection (LTBI) Testing market segmented into
Tuberculin Skin Test (TST)
Interferon Gamma Released Assay (IGRA)
Others

Based on the end-use, the global Latent Tuberculosis Infection (LTBI) Testing market classified into
Household Contacts with Pulmonary TB
PLHIV
Others

Based on geography, the global Latent Tuberculosis Infection (LTBI) Testing market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]

And the major players included in the report are
Qiagen
BioMerieux
Thermo Fisher Scientific
Danaher
Roche
Becton Dickinson
Agilent Technologies
Bio-Rad Laboratories
Eppendorf
Abbott Laboratories
Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL LATENT TUBERCULOSIS INFECTION (LTBI) TESTING INDUSTRY
2.1 Summary about Latent Tuberculosis Infection (LTBI) Testing Industry
2.2 Latent Tuberculosis Infection (LTBI) Testing Market Trends
2.2.1 Latent Tuberculosis Infection (LTBI) Testing Production & Consumption Trends
2.2.2 Latent Tuberculosis Infection (LTBI) Testing Demand Structure Trends
2.3 Latent Tuberculosis Infection (LTBI) Testing Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Tuberculin Skin Test (TST)
4.2.2 Interferon Gamma Released Assay (IGRA)
4.2.3 Others
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Household Contacts with Pulmonary TB
4.3.2 PLHIV
4.3.3 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Tuberculin Skin Test (TST)
5.2.2 Interferon Gamma Released Assay (IGRA)
5.2.3 Others
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Household Contacts with Pulmonary TB
5.3.2 PLHIV
5.3.3 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Tuberculin Skin Test (TST)
6.2.2 Interferon Gamma Released Assay (IGRA)
6.2.3 Others
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Household Contacts with Pulmonary TB
6.3.2 PLHIV
6.3.3 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Tuberculin Skin Test (TST)
7.2.2 Interferon Gamma Released Assay (IGRA)
7.2.3 Others
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Household Contacts with Pulmonary TB
7.3.2 PLHIV
7.3.3 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Tuberculin Skin Test (TST)
8.2.2 Interferon Gamma Released Assay (IGRA)
8.2.3 Others
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Household Contacts with Pulmonary TB
8.3.2 PLHIV
8.3.3 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Tuberculin Skin Test (TST)
9.2.2 Interferon Gamma Released Assay (IGRA)
9.2.3 Others
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Household Contacts with Pulmonary TB
9.3.2 PLHIV
9.3.3 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Qiagen
10.1.2 BioMerieux
10.1.3 Thermo Fisher Scientific
10.1.4 Danaher
10.1.5 Roche
10.1.6 Becton Dickinson
10.1.7 Agilent Technologies
10.1.8 Bio-Rad Laboratories
10.1.9 Eppendorf
10.1.10 Abbott Laboratories
10.2 Latent Tuberculosis Infection (LTBI) Testing Sales Date of Major Players (2017-2020e)
10.2.1 Qiagen
10.2.2 BioMerieux
10.2.3 Thermo Fisher Scientific
10.2.4 Danaher
10.2.5 Roche
10.2.6 Becton Dickinson
10.2.7 Agilent Technologies
10.2.8 Bio-Rad Laboratories
10.2.9 Eppendorf
10.2.10 Abbott Laboratories
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
  • FORMAT: PDF
  • PUBLISHED DATE: Jan, 2021
  • NO OF PAGES: 112